Consilium Wealth Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Sell |
3,032
-305
| -9% | -$238K | 1% | 24 |
|
|
2025
Q1 | $2.76M | Buy |
3,337
+137
| +4% | +$113K | 1.38% | 20 |
|
|
2024
Q4 | $2.47M | Sell |
3,200
-782
| -20% | -$604K | 1.18% | 23 |
|
|
2024
Q3 | $3.53M | Sell |
3,982
-545
| -12% | -$483K | 1.93% | 15 |
|
|
2024
Q2 | $4.1M | Sell |
4,527
-24
| -0.5% | -$21.7K | 2.24% | 14 |
|
|
2024
Q1 | $3.54M | Buy |
4,551
+10
| +0.2% | +$7.78K | 1.99% | 17 |
|
|
2023
Q4 | $2.65M | Buy |
4,541
+246
| +6% | +$143K | 1.59% | 19 |
|
|
2023
Q3 | $2.31M | Buy |
4,295
+161
| +4% | +$86.5K | 1.62% | 19 |
|
|
2023
Q2 | $1.94M | Buy |
4,134
+313
| +8% | +$147K | 1.34% | 19 |
|
|
2023
Q1 | $1.31M | Sell |
3,821
-827
| -18% | -$284K | 1.12% | 18 |
|
|
2022
Q4 | $1.7M | Sell |
4,648
-224
| -5% | -$81.9K | 1.45% | 16 |
|
|
2022
Q3 | $1.58M | Buy |
4,872
+53
| +1% | +$17.1K | 1.76% | 14 |
|
|
2022
Q2 | $1.56M | Buy |
4,819
+27
| +0.6% | +$8.75K | 1.68% | 17 |
|
|
2022
Q1 | $1.37M | Sell |
4,792
-324
| -6% | -$92.8K | 0.98% | 25 |
|
|
2021
Q4 | $1.41M | Buy |
+5,116
| New | +$1.41M | 0.92% | 24 |
|